143 related articles for article (PubMed ID: 19412190)
1. Therapy: A local approach to Raynaud phenomenon.
Herrick AL
Nat Rev Rheumatol; 2009 May; 5(5):246-7. PubMed ID: 19412190
[TBL] [Abstract][Full Text] [Related]
2. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon.
Hummers LK; Dugowson CE; Dechow FJ; Wise RA; Gregory J; Michalek J; Yenokyan G; McGready J; Wigley FM
Ann Rheum Dis; 2013 Dec; 72(12):1962-7. PubMed ID: 23268365
[TBL] [Abstract][Full Text] [Related]
3. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis.
Anderson ME; Moore TL; Hollis S; Jayson MI; King TA; Herrick AL
Rheumatology (Oxford); 2002 Mar; 41(3):324-8. PubMed ID: 11934971
[TBL] [Abstract][Full Text] [Related]
4. Topical nitroglycerin ointment in Raynaud's phenomenon.
Fischer M; Reinhold B; Falck H; Török M; Alexander K
Z Kardiol; 1985 May; 74(5):298-302. PubMed ID: 3925656
[TBL] [Abstract][Full Text] [Related]
5. Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate.
Hughes M; Moore T; Manning J; Wilkinson J; Dinsdale G; Roberts C; Murray A; Herrick AL
Microvasc Res; 2017 May; 111():32-36. PubMed ID: 28027937
[TBL] [Abstract][Full Text] [Related]
6. Use of nitroglycerin ointment to treat primary and secondary Raynaud's phenomenon: a systematic literature review.
Qiu O; Chan T; Luen M; Cruz JE; Hermes-DeSantis ER
Rheumatol Int; 2018 Dec; 38(12):2209-2216. PubMed ID: 30155665
[TBL] [Abstract][Full Text] [Related]
7. A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon.
Antcliff AC; Bouhoutsos J; Martin P; Morris T
Angiology; 1974 May; 25(5):312-6. PubMed ID: 4823806
[No Abstract] [Full Text] [Related]
8. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon].
Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL
J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055
[TBL] [Abstract][Full Text] [Related]
9. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
Chung L; Shapiro L; Fiorentino D; Baron M; Shanahan J; Sule S; Hsu V; Rothfield N; Steen V; Martin RW; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Gilbert A; Dechow FJ; Gregory J; Wigley FM
Arthritis Rheum; 2009 Mar; 60(3):870-7. PubMed ID: 19248104
[TBL] [Abstract][Full Text] [Related]
10. [Effect of nitroglycerin on finger artery blood pressure].
Hänsgen K; Podhaisky H; Sternitzky R
Vasa Suppl; 1991; 32():396-401. PubMed ID: 1771543
[No Abstract] [Full Text] [Related]
11. Objective relief of vasospasm by glyceryl trinitrate in secondary Raynaud's phenomenon.
Coppock JS; Hardman JM; Bacon PA; Woods KL; Kendall MJ
Postgrad Med J; 1986 Jan; 62(723):15-8. PubMed ID: 3099273
[TBL] [Abstract][Full Text] [Related]
12. [The influence of isosorbide mononitrate on skin blood flow in patients with Raynaud's syndrome].
Gross R; Galus K; Zajac S; Jedrasik M
Wiad Lek; 2002; 55(1-2):29-34. PubMed ID: 12043312
[TBL] [Abstract][Full Text] [Related]
13. Mesoglycan treatment in Raynaud phenomenon: a case series.
Di Biase A
Minerva Cardioangiol; 2013 Jun; 61(3):323-31. PubMed ID: 23681135
[TBL] [Abstract][Full Text] [Related]
14. Vasospasmolytic therapy in patients with SSC.
Jünger M; Schlez A; Klyscz T; Steins A; Hahn M
Adv Exp Med Biol; 1999; 455():305-7. PubMed ID: 10599360
[No Abstract] [Full Text] [Related]
15. [How I treat...Raynaud's phenomenon].
Piérard GE
Rev Med Liege; 1998 Mar; 53(3):119-20. PubMed ID: 9594609
[TBL] [Abstract][Full Text] [Related]
16. Resolution of peripheral artery catheter-induced ischemic injury following prolonged treatment with topical nitroglycerin ointment in a newborn: a case report.
Vasquez P; Burd A; Mehta R; Hiatt M; Hegyi T
J Perinatol; 2003 Jun; 23(4):348-50. PubMed ID: 12774147
[TBL] [Abstract][Full Text] [Related]
17. [Local administration of cerebrolysin in Raynaud's disease in a 2-year-old child].
Osipenko TN; Skvortsov IA; Korshunov SV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):100-3. PubMed ID: 1661499
[TBL] [Abstract][Full Text] [Related]
18. [Nitrates at high altitude, that is the inappropriate use of a drug].
Donegani E
G Ital Cardiol (Rome); 2011 Dec; 12(12):824-8. PubMed ID: 22158453
[No Abstract] [Full Text] [Related]
19. Laser Doppler imaging evaluation of nitroglycerin patch application in systemic sclerosis patients.
Pintea Bentea G; Wauters A; Wautrecht JC; Cogan E
Vasc Med; 2020 Dec; 25(6):559-568. PubMed ID: 32990196
[TBL] [Abstract][Full Text] [Related]
20. Raynaud's phenomenon.
Solomons HD
Cardiovasc J Afr; 2011; 22(5):233. PubMed ID: 21983952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
